Authors

• Lei Zhao (ORCID: https://orcid.org/0000-0001-5027-2379)
• Lei M. Li (ORCID: https://orcid.org/0000-0002-6571-1079)
• Yalikun Kugeluke
• Zhongchao Li (ORCID: https://orcid.org/0000-0001-7529-2587)
• Bo Zhang (ORCID: https://orcid.org/0000-0002-7642-8973)
• Mingming Li (ORCID: https://orcid.org/0009-0004-6650-9974)
• Jianxin Zhang (ORCID: https://orcid.org/0000-0001-8165-1371)
• Zhicheng Sun
• Lei Xu (ORCID: https://orcid.org/0000-0002-5072-5080)
• Pengfei Sun (ORCID: https://orcid.org/0000-0002-6016-1872)
• Yue Yang (ORCID: https://orcid.org/0000-0001-9489-134X)
• Jingtao Zhong (ORCID: https://orcid.org/0000-0003-3686-9720)
• Chengsheng Zhang (ORCID: https://orcid.org/0000-0002-5238-083X)
• Kai Cui (ORCID: https://orcid.org/0000-0002-7614-4591)
• Zhibin Chang
• Xuetao Shi
• Zhaogang Liu

Institutions

• Xinjiang Medical University (CN)
• Tumor Hospital of Xinjiang Medical University (CN)
• Shandong First Medical University (CN)

Publication Details

Journal

BMC Cancer

Published

2025-05-07

DOI

https://doi.org/10.1186/s12885-025-14250-5

Citations

6

Primary Topic

Hepatocellular Carcinoma Treatment and Prognosis

Type

article

Field-Weighted Citation Impact

7.93

Funders

• National Natural Science Foundation of China
• Wu Jieping Medical Foundation